Prospective evaluation of (68) Ga-DOTATATE PET/CT in limited disease neuroendocrine tumours and/or elevated serum neuroendocrine biomarkers.

Gabriel S, Garrigue P, Dahan L, Castinetti F, Sebag F, Baumstark K, Archange C, Jha A, Pacak K, Guillet B, Taïeb D

Open source

DOI
10.1111/cen.13745
Published
2018 Aug
Container
Clinical endocrinology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/cen.13745,
  title = {Prospective evaluation of (68) Ga-DOTATATE PET/CT in limited disease neuroendocrine tumours and/or elevated serum neuroendocrine biomarkers.},
  author = {Gabriel S and Garrigue P and Dahan L and Castinetti F and Sebag F and Baumstark K and Archange C and Jha A and Pacak K and Guillet B and Taïeb D},
  year = {2018},
  journal = {Clinical endocrinology},
  doi = {10.1111/cen.13745},
  url = {https://doi.org/10.1111/cen.13745}
}

RIS

TY  - JOUR
TI  - Prospective evaluation of (68) Ga-DOTATATE PET/CT in limited disease neuroendocrine tumours and/or elevated serum neuroendocrine biomarkers.
AU  - Gabriel S
AU  - Garrigue P
AU  - Dahan L
AU  - Castinetti F
AU  - Sebag F
AU  - Baumstark K
AU  - Archange C
AU  - Jha A
AU  - Pacak K
AU  - Guillet B
AU  - Taïeb D
PY  - 2018
JO  - Clinical endocrinology
DO  - 10.1111/cen.13745
UR  - https://doi.org/10.1111/cen.13745
ER  - 

APA

S, G., P, G., L, D., F, C., F, S., K, B., C, A., A, J., K, P., B, G., & D, T. (2018). Prospective evaluation of (68) Ga-DOTATATE PET/CT in limited disease neuroendocrine tumours and/or elevated serum neuroendocrine biomarkers.. Clinical endocrinology. https://doi.org/10.1111/cen.13745

Source records